Please select an option below to help us tailor your newsletter to best suit your content interests!
West Cancer Center, Memphis, Tennessee; City of Hope Comprehensive Cancer Center, Duarte, California; Mays Cancer Center, home to UT Health San Antonio MD Anderson, San Antonio, Texas; O’Neal Comprehensive Cancer Center, and University of Alabama at Birmingham, Birmingham, Alabama; comprise the new Advancing Inclusive Research® Site Alliance. This coalition of clinical research sites aims to advance the representation… Read more »
Meet Ken, a West Cancer Center metastatic melanoma survivor. Ken recently shared his Cancer Survivorship Story with us as we hope to spread these journeys of hope, achievement and encouragement this month! Here is Ken’s story: “My personal journey with #melanoma began long before my first #skincancer diagnosis. I grew up near… Read more »
West Cancer Center and Saint Francis Healthcare Announce Joint Relationship New affiliation includes first-in-the-Mid-South cancer urgent care center West Cancer Center and Research Institute and Saint Francis Healthcare today announced an agreement to advance and increase access to cancer care in the Mid-South. This collaboration is supported by multi-million dollar investments in cancer… Read more »
West Fight On returns to Shelby Farms Park on September 11, 2021 Get ready to cycle, run, or walk to beat cancer! West Fight On benefiting West Cancer Foundation will be LIVE and IN-PERSON this September! This signature fundraising event will return to its home at Shelby Farms Park on Saturday, September 11,… Read more »
Here at West Cancer Center & Research Institute, we are proud to host our own virtual tumor boards, or Multidisciplinary Conferences, multiple times each week. In these multidisciplinary conferences, we bring together a variety of providers from different disciplines and even institutions to talk about patient cases. It is in these conferences that a group… Read more »
Dr. Daniel Vaena, Director of Experimental Therapeutics Program at West Cancer Center Research Institute, co-presented updated data from Compugen Ltd.’s Phase 1 dose escalation and expansion study of COM701 as a monotherapy, and in a dose escalation combination study with Opdivo® (nivolumab) Vaena states “Although these results are very preliminary, they suggest that targeting… Read more »
It is with great excitement that our West Cancer Center and Research Institute network adds a new leadership role to our Division of Pharmacy. Camille Hill, PharmD has recently accepted a newly created role of Vice President of Oncology Pharmacy Services, which has become a vital aspect for our network as West continues to grow…. Read more »
Click here to view this full article on OncLive.com. The addition of immune checkpoint inhibitors to chemotherapy has led to durable responses and improved survival without increased toxicity in patients with small cell lung cancer (SCLC), according to David C. Portnoy, MD, FACP, who added that biomarkers of response to this approach and a… Read more »
Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »
West Cancer Center & Research Institute's faculty participates in numerous Tumor Boards throughout the year which brings together physicians across specialties to evaluate individual patient cases and develop a collective recommendation for treatment. This collaborative approach puts our patient's care at the center; surrounded by a team of specialists including surgical oncologists, medical oncologists, radiation... Read more »